Syntrillo Telehealth Stroke Risk Reduction Study
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age30+
SponsorSyntrillo, Inc
About this trial
A prospective, single-arm, open-label study evaluating the impact of Syntrillo's telehealth program on stroke risk factors, particularly blood pressure, among 68 high-risk patients. The 6-month intervention includes personalized remote care with blood pressure monitoring, wearable tracking, and multidisciplinary telehealth visits.
Eligibility criteria
Qualifiers
Age greater than or equal to 30
Diagnosis of hypertension
Dtrial fibrillation
Diabetes
Disqualifiers
History of stroke or TIA
Inability to consent or understand study
Residence in long-term acute care facility
Inability to ambulate independently
Trial design
Treatments tested in this trial
- Technology-enabled Telehealth Care Plan
- Blood Pressure Monitoring Device
- Tenovi Smart Pillbox
- Wearable Activity Trackers (Fitbit or Apple Watch)
- Healthie EHR
- Secure Messaging Platforms (TigerConnect, Weave, AirCall)
- Antihypertensive Medication Management
- Statin Medication Management
- Antiplatelet or Anticoagulant Therapy
- Laboratory Blood Test Collection
Treatment groups
68 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov